Project Cerise - Charles Taylor

Project Cerise

The proposed Joint Administrators are seeking parties interested in the business and assets of a company that specialises in personalised hormone replacement therapy, at home blood testing, personalized treatment plans and ongoing monitoring and follow up care to patients.

Key Features:

Based in North West

Operates from Leasehold premises

Current turnover for the 10 month period ending October 2026 of £4.4m.

Turnover for the year ended December 2025 of £4.13m

24 employees

 

 

Opportunity:

 

Assets available for sale include:

 

Goodwill including Intellectual Property and Brand;

Digital assets – website, social media, paid-ad accounts;

Patient base and recurring revenue;

Marketing database;

Clinical and operational protocols and registered workforce;

Office Furniture and Computer Equipment; and

Medical Equipment.

 

 

Offers:

 

Deadline for offers are required by 12:00 noon Thursday 12 November 2026 with a view to completion shortly thereafter.

All interested parties will be required to sign a non-disclosure agreement.

Proof of funding required.

Contact Details

Email

helen.hales@leonardcurtis.co.uk

Phone

0161 831 9999

Location

Riverside House, Irwell Street, Manchester, M3 5EN

Sign up to our mailing list

Stay in the loop with the latest news, auctions and updates.

Sign Up Now